To further validate the protein expression of AMIGO2 and explore its potential biological relevance in PAAD, we conducted integrative analyses combining immunohistochemistry (IHC), EMT-related transcription factor correlation, and immune infiltration profiling. This evidence concerns the gene AMIGO2 and pancreatic adenocarcinoma.